Significance of CD44v6 expression in gynecologic malignancies

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 4, 2006, Pages 379-386

  Soon, Cheol Hong ^a   Jae, Yun Song ^a   Jae, Kwan Lee ^a   Nak, Woo Lee ^a   Sun, Haeng Kim ^a   Bom, Woo Yeom ^a   Kyu, Wan Lee ^a  

^a Korea University Ansan Hospital   (South Korea)

Author keywords

CD44v6; Gynecologic malignancy; Immunohistochemical stain

Indexed keywords

CD44V6 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; EARLY CANCER; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVARY TUMOR; PROGNOSIS; STROMA CELL; TISSUE SECTION; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIGENS, CD44; FEMALE; GENITAL NEOPLASMS, FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 33745874694     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00422.x     Document Type: Article

References (40)

1. Freemont AJ. Demystified . . . adhesion molecules. Mol Pathol 1998; 51: 175-184.
2. Miletti-Gonzalez KE, Chen S, Muthukumaran N et al. The CD44 receptor interacts with P-Glycoprotein to promote cell migration and invasion in cancer. Cancer Res 2005; 65: 6660-6667.
3. Lesley J, Hyman R, English N, Catterall JB, Turner GA. CD44 in inflammation and metastasis. Glycoconj J 1997; 14: 611-622.
4. Herrera-Gayol A, Jothy S. Adhesion proteins in the biology of breast cancer; contribution of CD44. Exp Mol Pathol 1999; 66: 149-156.
5. Kaufmann M, Heider KH, Sinn HP, Minckwitz G, Ponta H, Herlich P. CD44 variant exon epotopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
6. Woodman AC, Sugiyama M, Yoshida K et al. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol 1996; 149: 1519-1530.
7. Barbour AP, Reeder JA, Walsh MD, Favcett J, Antalis TM, Gotley DC. Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Res 2003; 63: 887-892.
8. Xin Y, Grace A, Gallagher MM, Curran BT, Leader MB, Kay EW. CD44v6 in gastric carcinoma: A marker of tumor progression. Appl Immunohistochem Mol Morph 2001; 9: 138-142.
9. Yamaguchi A, Goi T, Yu J et al. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol 2002; 79: 230-235.
10. Shimbori M, Kijima H, Sato S. Expression of CD44 in primary lung carcinomas using histological and cytological analyses. Anticancer Res 2003; 23: 115-121.
11. Lucin K, Matusan K, Dordevic G, Stipic D. Prognostic significance of CD44 molecule in renal cell carcinoma. Croat Med J 2004; 45: 703-708.
12. Ma W, Deng Y, Zhou L. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: A clinicopathologic study. Clin Oncol 2005; 17: 258-263.
13. Lockhart MS, Waldner C, Mongini C et al. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma. Oncol Rep 1999; 6: 1129-1133.
14. Speiser P, Wanner C, Tempfer C et al. CD44 is an independent prognostic factor in early stage cervical cancer. Int J Cancer 1997; 74: 185-188.
15. Speiser P, Kridelka F, Tempfer C et al. CD44v6 expression is an independent prognostic factor in node-negative FIGO stage I B cervical carcinoma. Int J Gynecol Cancer 1999; 9: 160-165.
16. Ayhan A, Bayka C, Al A, Ayhan A. Altered CD44 variant 6 expression in FIGO stage I B cervical carcinoma. Gynecol Oncol 2001; 83: 569-574.
17. Kainz C, Kohlberger P, Tempfer C et al. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 1995; 31: 1706-1709.
18. Kainz C, Kohlberger P, Sliutz G et al. Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol 1995; 57: 383-387.
19. Tokumo K, Kodama J, Seki N, Miyagi Y, Yoshinouchi M, Kudo T. CD44 Exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Eur J Cancer 1998; 34: 2107-2111.
20. Saegusa M, Hashimura M, Machida D, Okayasu I. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumors. J Pathol 1999; 187: 173-183.
21. Horn LC, Raptis G, Fischer U et al. CD44-v6 concentrations in carcinoma of the uterine cervix: Lack of prognostic significance. Arch Gynecol Obstet 2005; 273: 104-106.
22. Shimabukuro K, Toyamo-Sorimachi N, Ozaki Y et al. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Gynecol Oncol 1997; 64: 26-34.
23. Dellas A, Schultheiss E, Almendral AC, Torhost J, Gudat F. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol 1996; 62: 218-225.
24. Kohlberger PD, Kieback DG, Bancher D et al. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium. Gynecol Oncol 1997; 66: 227-232.
25. Callagy G, MRCPI, O'Grady A et al. Expression of CD44 in uterine cervical squamous neoplasia: A predictor of microinvasion? Gynecol Oncol 2000; 76: 73-79.
26. Ayhan A, Tok EC, Bildirici I, Ayhan A. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance. Gynecol Oncol 2001; 80: 355-358.
27. Stokes GN, Shelton JB, Zahn CM, Kendall BS. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma. Gynecol Oncol 2002; 84: 58-61.
28. Katsura M, Furumoto H, Nishimura M, Kamada M, Aono T. Overexpression of CD44 variants 6 and 7 in human endometrial cancer. Gynecol Oncol 1998; 71: 185-189.
29. Saegusa M, Hashimura M, Okayasu I. CD44 expression in normal, hyperplastic, and malignant endometrium. J Pathol 1998; 184: 297-306.
30. Tokumo K, Kodama J, Seki N, Miyagi Y, Yoshinouchi M, Kudo T. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer. Cancer Lett 1998; 125: 221-225.
31. Leblanc M, Poncelet C, Soriano D et al. Alteration of CD44 and cadherins expression: Possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchows Arch 2001; 438: 78-85.
32. Sillanpää A, Anttila MA, Voutilainen K et al. CD44 expression indicates favorable prognosis in epithelial ovarian cancer. Clin Cancer Res 2003; 9: 5318-5324.
33. Ross JS, Sheehan CE, William SS, Malfetano JH, Szyfelbein WM, Kallakury B. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol 2001; 116: 122-128.
34. Darai E, Walker-Combrouze F, Fauconnier A, Madelenat P, Potet F, Scoazec J. Analysis of CD44 expression in serous and mucinous borderline tumors of the ovary: Comparison with cystadenomas and overt carcinomas. Histopathology 1998; 32: 151-159.
35. Berner HS, Davidson B, Berner A et al. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications. Clin Exp Metastasis 2000; 18: 197-202.
36. Saegusa M, Machida D, Hashimura M, Okayasu I. CD44 expression in benign, premalignant, and malignant ovarian neoplasm: Relation to tumour development and progression. J Pathol 1999; 189: 326-337.
37. Cannistra SA, Abu-Jawdeh G, Niloff J et al. CD44 variant expression is a common feature of epithelial ovarian cancer: Lack of association with standard prognostic factors. J Clin Oncol 1995; 13: 1912-1921.
38. Rodriguez-Rodriguez L, Sanch-Torres I, Mesonero C, Gibbon DG, Shih WJ, Zotalis G. The CD44 receptor is a molecular predictor of survival in ovarian cancer. Med Oncol 2003; 20: 255-263.
39. Hefler LA, Concin N, Mincham D et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma. Cancer 2002; 94: 125-130.
40. Qu P, Jiao S, Gao Q. Clinical significance of CD44 expression in ovarian epithelial tumors (abstract). Zhonghua Zhong Liu Za Zhi 2001; 23: 46-49.